Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02487745 · ClinicalTrials.gov registry record · NA
The Long-Term Treatment of Drug Addiction and Unemployment
A NA study, sponsored by Johns Hopkins University.
- Completed
- Registry status
- NA
- Development phase
- 91
- Enrollment target
NCT02487745: Completed NA study, sponsored by Johns Hopkins University.
NCT02487745 is a NA study that has completed, run by Johns Hopkins University. The registered enrollment target is 91 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02487745, a NA study, has completed, sponsored by Johns Hopkins University.
- COMPLETED
- Registry status
- NA
- Development phase
- 91 participants
- Enrollment target
Study Summary
The purpose of this clinical trial is to evaluate the effectiveness and economic benefits of a Wage Supplement Model of arranging long-term exposure to employment-based abstinence reinforcement.
Primary Outcome
(# opiate- and cocaine-negative urine samples/divided by possible #) x 100
Interventions
- BEHAVIORAL Abstinence-contingent wage supplements
- BEHAVIORAL Individual Placement and Support (IPS) supported employment
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 91 participants |
| Start Date | 2015-11 |
| Est. Completion | 2020-09 |
| Phase | NA |
What the finished NCT02487745 record still lists
NCT02487745 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 91 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower).
The record links to 0 conditions, and to 2 interventions - of which Abstinence-contingent wage supplements is the first listed.
NCT02487745 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02487745 about?
NCT02487745 is a clinical study titled "The Long-Term Treatment of Drug Addiction and Unemployment". The purpose of this clinical trial is to evaluate the effectiveness and economic benefits of a Wage Supplement Model of arranging long-term exposure to employment-based abstinence reinforcement.
What is the current status of trial NCT02487745?
This trial is currently completed. It is a NA study. The enrollment target is 91 participants. The study started on 2015-11. Estimated completion is 2020-09.
What interventions are being tested in trial NCT02487745?
The interventions under investigation include: Abstinence-contingent wage supplements (BEHAVIORAL), Individual Placement and Support (IPS) supported employment (BEHAVIORAL).
Who is sponsoring clinical trial NCT02487745?
This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02487745's enrollment target sits among peer trials
91 939th of 2000 higher than 1,060 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02671448 · 91 participants · NA
Pilot Trial of Homebound Stem Cell Transplantation
- NCT04835857 · 91 participants
Comparison of Cuff-Less Wrist Wearable Blood Pressure Device to Cuff Based Blood Pressure Measuring Devices
- NCT05184842 · 91 participants · Phase 2
Metabolically Optimized, Non-cytotoxic Low Dose Weekly Decitabine/Venetoclax in MDS and AML
- NCT05685173 · 91 participants · Phase 1
A Trial to Study if REGN5837 in Combination With Odronextamab is Safe for Adult Participants With Aggressive B-cell Non-Hodgkin Lymphomas
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia